Silo Pharma, Inc. (NASDAQ:SILO) Financings

Silo Pharma, Inc.

Financings

RaiseDate
Private placement of common stock (or pre-funded warrants) with Series A-3 and Series A-4 warrants
Announced: about US$4M · US$6.452 a share · Warrants at US$6.21 · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Jul 10, 2026
Registered direct offering of shares of common stock with concurrent unregistered warrants
Closed: US$2.5M raised · US$0.875 a share · Warrants at US$0.75 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: Working capital and general corporate purposes
Oct 1, 2025
Public offering of shares of common stock (or pre-funded warrants) with series A-1 and A-2 warrants
Closed: US$2M raised · US$0.6 a share · Warrants at US$0.6 for 60 months · H.C. Wainwright & Co.
Dealers: H.C. Wainwright & Co. (lead)
Use of proceeds: General working capital purposes
May 16, 2025

Read by 6ix AI from the company's releases